Validation of the Korean version of visual analogue scale for irritable bowel syndrome questionnaire for assessment of defecation pattern changes

Yoo, Hye Jin; Park, Boram; Joo, Jungnam; Kim, Jung Sup; Lee, Yumi; Lim, Myong Cheol; Sohn, Dae Kyung; Kang, Sung Bum; Park, Kyu Joo

doi:10.4174/astr.2018.94.5.254

Cited by 3 publications

(4 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…According to ROME IV, IBS is characterized by the change in shape and consistency of more than one fourth of the stools in the last 3 months (10). By difference to Hong Yeol Yoo et al (9) who developed the Korean version of the VAS-IBS, we observed that most of the patients had no inconvenience to answer to Bristol stool scale item, even if it was to differentiate between intermediary stool shapes (answers between 3 and 5).…”

Section: Resultsmentioning

confidence: 56%

See 1 more Smart Citation

"Validation of romanian version of visual analogue scale for irritable bowel syndrome questionnaire (VAS-IBS)"

Balmuș¹,

Cojocariu²,

Ciobîcă³

et al. 2020

BPI

View full text Add to dashboard Cite

Purpose: Quality of life (Qol) is undoubtedly important for patient case management. The Irritable Bowel Syndrome (IBS) is one of the most common functional gastrointestinal disorders which disturbs the daily life of individuals and potentially affects emotional status and quality of life. Visual analogue scale for IBS (VAS-IBS) is a well-known symptom severity rating scale proposed as an instrument which could be clinically used to evaluate the perceived severity of IBS symptoms in patients over time. In this study, we aimed to translate, adapt and validate the VAS-IBS to Romanian language and culture. The translation, adaptation and validation of the Romanian version of VAS-IBS were possible without many limitations due to some similarities between Romanian and Western cultures. Thus, according to our results, the final form of Romanian VAS-IBS can be considered a reliable tool in measuring the perceived severity of gastrointestinal symptoms which can be classified by 64/Bulletin of Integrative Psychiatry New Series  March 2020  Year XXVI  No. 1 (84) ROME IV as IBS symptoms, as this could also have an increased relevance in the context of the associated psychiatric disorders of IBS. KEYWORDS: ROME IV, irritable bowel syndrome, visual analogue scale, questionnaire, quality of life.

show abstract

Section: Resultsmentioning

confidence: 56%

“…Cronbach's alpha was used to assess the validity of the questionnaire considering all the participants and items 2, 4 and 5. Intraclass correlation coefficient was used to assess reproducibility (9).…”

Section: Discussionmentioning

confidence: 99%

"Validation of romanian version of visual analogue scale for irritable bowel syndrome questionnaire (VAS-IBS)"

Balmuș¹,

Cojocariu²,

Ciobîcă³

et al. 2020

BPI

View full text Add to dashboard Cite

show abstract

“…Considering that IBS is the most common biopsychosocial disorder having a multifactorial pathogenesis (Drossman, 2006), this questionnaire should be regarded as a one-dimensional tool. Therefore, Alpha if Item Deleted was used to assess the homogeneity after item reduction, the Cronbach's alpha for validity (a minimum coefficient of .70 is required, but not higher than .90) (Norman and Cairney, 2015; Polit and Hungler, 1989), whereas intraclass correlation for reproducibility (Yoo et al, 2018) (Table 1).…”

Section: Resultsmentioning

confidence: 99%

Preliminary Data on Gastrointestinal Deficiencies Incidence and the Prevalence of Anxiety During the COVID-19 Pandemic Among the Medical Workers

et al. 2021

View full text Add to dashboard Cite

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly contagious new β-coronavirus that primarily affects the lungs. Because of its unprecedented spread, in a relatively short interval, it is declared a global pandemic. Binding to the angiotensin-converting enzyme 2 receptors, SARS-CoV-2 is easily disseminated through air. Apart from the established clinical panel, individuals exposed to prolonged chronic stress also manifest gastrointestinal (GI) symptoms similar to those exhibited by SARS-CoV-2-infected patients.The present study aims to assess the incidence of GI deficiencies and prevalence of anxiety among healthy medical staff by applying the Visual Analog Scale for Irritable Bowel Syndrome (VAS-IBS) and Hamilton Anxiety Rating Scale (HAM-A) during this global crisis.We found significant differences on several items of the VAS-IBS: regarding the incidence of diarrhea ( p = 0.04), bloating/gases ( p = 0.02), and nausea/ vomiting ( p = 0.01) from the physical spectrum. After stratification based on age of the participants and after we applied Kruskal-Wallis test because of heterogeneity between groups, we noted two situations in which the null hypothesis is rejected: nausea/vomiting in women between 20 and 30 years, and between 30 and 40, and between 40 and 50 years, respectively ( p = 0.026/0.029). Anxiety was prevalent among young and middle-class people after the centralization of HAM-A data, where 40.4% of the participants had various forms of anxiety: mild (n = 13; 13.82%), severe (n = 13; 13.82%), and moderate (n = 12; 12.76%).This study demonstrates that VAS-IBS is a reliable tool for assessing the incidence of GI deficiencies, as well as HAM-A for anxiety.

show abstract

“… 25 They also provided VAS scores (0: very good to 10: very bad) for the severity of IBS symptoms including abdominal pain, gas, and bloating, as well as for psychological well-being. 26 Stool form and consistency were evaluated using the BSC. 24 The primary end point was overall responder rates of improvement in global IBS symptoms.…”

Section: Methodsmentioning

confidence: 99%

Efficacy of a Synbiotic Containing Lactobacillus paracasei DKGF1 and Opuntia humifusa in Elderly Patients with Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial

Jang

Kang

et al. 2022

Gut and Liver

View full text Add to dashboard Cite

Background/Aims There is increasing evidence that supplementation with pre- and probiotics appears to have positive effects on irritable bowel syndrome (IBS). The aim of this study was to determine the effects of a new synbiotic formulation on gastrointestinal symptoms in elderly patients with IBS. Methods Sixty-seven IBS patients aged ≥60 years were randomly assigned to either a placebo group (n=34) or a synbiotic group (n=33). During a 4-week intervention, subjects used a placebo or a synbiotic containing Lactobacillus paracasei DKGF1 and extracts of Opuntia humifusa once a day. Patients were evaluated with the subject global assessment, visual analog scale, and Bristol stool chart. The primary outcome was the overall responder rate and the secondary outcome was the responder rates for abdominal symptom reduction at week 4. Results Overall, responder rates were significantly higher in the synbiotic group (51.5%) than in the placebo group (23.5%) (p=0.017). Abdominal pain (58.8% vs 81.8%) and psychological well-being (26.4% vs 60.6%) were noticeably improved in the synbiotic group (p=0.038 and p=0.004, respectively). However, there were no significant differences in gas and bloating symptoms (p=0.88 and p=0.88, respectively). In patients with constipation-dominant and diarrhea-dominant IBS (n=16), the synbiotic significantly improved abdominal pain and defecation symptoms (responder rates for the placebo vs the synbiotic 22.2% vs 85.7%, p=0.04). There were no adverse events in either group. Conclusions The results indicate that this new synbiotic supplement can potentially relieve abdominal symptoms in elderly IBS patients.

show abstract

Validation of the Korean version of visual analogue scale for irritable bowel syndrome questionnaire for assessment of defecation pattern changes

Cited by 3 publications

References 25 publications

"Validation of romanian version of visual analogue scale for irritable bowel syndrome questionnaire (VAS-IBS)"

"Validation of romanian version of visual analogue scale for irritable bowel syndrome questionnaire (VAS-IBS)"

Preliminary Data on Gastrointestinal Deficiencies Incidence and the Prevalence of Anxiety During the COVID-19 Pandemic Among the Medical Workers

Efficacy of a Synbiotic Containing Lactobacillus paracasei DKGF1 and Opuntia humifusa in Elderly Patients with Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial

Contact Info

Product

Resources

About